CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

Further Hazards of Mismatched Surgical Aortic Valve Prostheses

Published: Thu, 18 Jan 2018 16:48:30 EST
Survival suffers after a later transcatheter valve-in-valve procedure, should it be needed, if the failed surgical prosthetic valve wasn't originally up to the patient's cardiac output needs.
Medscape Medical News

Deep-Brain Stimulation Improves Tourette's Tics

Published: Thu, 18 Jan 2018 16:42:39 EST
Deep-brain stimulation significantly improves tics associated with Tourette's syndrome, a new registry-based study suggests.
Medscape Medical News

ADHD Prescriptions Skyrocket Among Young Women

Published: Thu, 18 Jan 2018 15:11:18 EST
A spike in ADHD drug use among young women is a 'public health concern,' given the uncertainty about the safety of using ADHD medications during pregnancy, federal health officials say.
Medscape Medical News
Displaying results 1-3 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

Switching off enzymes to block cell division in cancer

Published: Thu, 18 Jan 2018 17:57:09 +0000
Using mass spectrometry, researchers from Sweden and the U.K. have discovered how drugs bind to the enzyme DHODH, which could lay the groundwork for more selective cancer drugs that slow or stop cell division.

Gilead/Kite team up with Pfizer for CAR-T-mAb combination

Published: Thu, 18 Jan 2018 14:46:37 +0000
Gilead and its shiny new $12 billion biotech buy Kite Pharma have teamed up with Big Pharma Pfizer to work on a Yescarta-utomilumab combination test in certain blood cancers.

Inositec names ex-Roche, Novartis staffer as CMO

Published: Thu, 18 Jan 2018 10:59:19 +0000
Inositec has named former Roche and Novartis staffer Frits van Alphen, M.D., as its CMO. Van Alphen joins Inositec as the biotech gears up to move its lead vascular calcification candidate into the clinic next year.
Displaying results 1-3 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code
1-800-4-the-clinx

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top